15 Biggest Mid-Day Losers For Friday

Loading...
Loading...
  • Finisar Corporation FNSR shares dropped 19.4 percent to $28.12 after the company reported weaker-than-expected results for its third quarter and issued disappointing forecast for the current quarter.
  • Ocera Therapeutics Inc OCRX shares tumbled 19.1 percent to $1.53. Ocera Therapeutics reported a Q4 loss of $0.22 per share.
  • Inseego Corp INSG dropped 19 percent to $2.31. Inseego posted a wider-than-expected quarterly loss.
  • Mueller Industries, Inc. MLI shares fell 18.3 percent to $31.78.
  • TearLab Corp TEAR shares declined 17.6 percent to $3.88. Tearlab reported a Q4 loss of $0.81 per share on revenue of $7.121 million. The company also disclosed that it has begun process to explore strategic alternatives.
  • Zumiez Inc. ZUMZ tumbled 13.2 percent to $18.23. Zumiez posted upbeat results for its fourth quarter. However, the company issued a downbeat guidance for the current quarter.
  • CECO Environmental Corp. CECE dropped 13.3 percent to $10.19. CECO Environmental reported Q4 adjusted earnings of $0.35 per share on revenue of $100 million.
  • Smith Micro Software, Inc. SMSI fell 12.9 percent to $1.18 on downbeat quarterly results.
  • Second Sight Medical Products Inc EYES shares declined 12.3 percent to $1.36. Second Sight reported a Q4 adjusted loss of $0.17 per share.
  • MeetMe Inc MEET dropped 11.2 percent to $5.16. MeetMe reported an offering of common shares.
  • Ionis Pharmaceuticals Inc IONS shares dipped 10.4 percent to $41.02. Goldman Sachs downgraded Ionis Pharmaceuticals from Neutral to Sell.
  • Sears Hometown and Outlet Stores Inc SHOS dropped 9.6 percent to $3.30. Sears Hometown reported a Q4 loss of $45.8 million.
  • Surgery Partners Inc SGRY declined 8.7 percent to $19.12 after the company posted weaker-than-expected quarterly profit.
  • Alexandria Real Estate Equities Inc ARE fell 4.2 percent to $108.98. Alexandria Real Estate Equities priced public offering of 6.1 million shares of common stock at $108.55 per share.
  • Cara Therapeutics Inc CARA fell 3.7 percent to $16.85 after the company reported a wider-than-expected quarterly loss.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...